The Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Market is estimated to be valued at USD 1.41 Bn in 2024 and is expected to reach USD 2.03 Bn by 2031, growing at a compound annual growth rate (CAGR) of 7.11% from 2024 to 2031. https://www.writerscafe.org/kirtitawale/blogs/The-Global-Chronic-Thromboembolic-Pulmonary-Hypertension-%28CTEPH%29-Market-is-Primed-to-Flourish-Due-to-Rising-Disease-Prevalence/246502/